Want to see IN:SOLARA full AI Analyst Report?
Total Valuation
Solara Active Pharma Sciences Ltd. has a market cap or net worth of ₹24.50B. The enterprise value is ₹33.31K.
Market Cap₹24.50B
Enterprise Value₹33.31K
Share Statistics
Solara Active Pharma Sciences Ltd. has 47,784,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,784,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Solara Active Pharma Sciences Ltd.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 4.36%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)4.36%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee6.35M
Profits Per Employee-34.37K
Employee Count2,156
Asset Turnover0.59
Inventory Turnover3.16
Valuation Ratios
The current PE Ratio of Solara Active Pharma Sciences Ltd. is ―. Solara Active Pharma Sciences Ltd.’s PEG ratio is 0.19.
PE Ratio―
PS Ratio1.37
PB Ratio1.50
Price to Fair Value1.50
Price to FCF211.37
Price to Operating Cash Flow32.22
PEG Ratio0.19
Income Statement
In the last 12 months, Solara Active Pharma Sciences Ltd. had revenue of 13.69B and earned -74.10M in profits. Earnings per share was -1.68.
Revenue13.69B
Gross Profit3.66B
Operating Income870.70M
Pretax Income-74.10M
Net Income-74.10M
EBITDA1.87B
Earnings Per Share (EPS)-1.68
Cash Flow
In the last 12 months, operating cash flow was 740.60M and capital expenditures -286.00M, giving a free cash flow of 454.60M billion.
Operating Cash Flow740.60M
Free Cash Flow454.60M
Free Cash Flow per Share9.51
Dividends & Yields
Solara Active Pharma Sciences Ltd. pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change-16.68%
50-Day Moving Average557.62
200-Day Moving Average533.91
Relative Strength Index (RSI)25.91
Average Volume (3m)37.94K
Important Dates
Solara Active Pharma Sciences Ltd. upcoming earnings date is Nov 11, 2026, TBA (Confirmed).
Last Earnings DateJul 23, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Solara Active Pharma Sciences Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 0.00%
Current Ratio0.96
Quick Ratio0.60
Debt to Market Cap0.36
Net Debt to EBITDA3.41
Interest Coverage Ratio0.92
Taxes
In the past 12 months, Solara Active Pharma Sciences Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Solara Active Pharma Sciences Ltd. EV to EBITDA ratio is 13.46, with an EV/FCF ratio of 283.02.
EV to Sales1.84
EV to EBITDA13.46
EV to Free Cash Flow283.02
EV to Operating Cash Flow40.73
Balance Sheet
Solara Active Pharma Sciences Ltd. has ₹533.40M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹533.40M billion.
Cash & Marketable Securities₹533.40M
Total Debt₹0.00
Net Cash₹533.40M
Net Cash Per Share₹11.16
Tangible Book Value Per Share₹196.90
Margins
Gross margin is 31.57%, with operating margin of 6.36%, and net profit margin of -0.54%.
Gross Margin31.57%
Operating Margin6.36%
Pretax Margin-0.54%
Net Profit Margin-0.54%
EBITDA Margin13.64%
EBIT Margin6.36%
Analyst Forecast
The average price target for Solara Active Pharma Sciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast15.49%
EPS Growth Forecast-108.86%